MCF Advisors LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
MCF Advisors LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$11,714
+0.9%
1150.0%0.00%0.0%
Q2 2023$11,605
+9.7%
1150.0%0.00%0.0%
Q1 2023$10,580
+1.4%
1150.0%0.00%0.0%
Q4 2022$10,433
-5.2%
115
-20.7%
0.00%0.0%
Q3 2022$11,000
-91.9%
145
-91.0%
0.00%
-92.9%
Q2 2022$136,000
-3.5%
1,6080.0%0.01%
+7.7%
Q1 2022$141,000
+1914.3%
1,608
+1885.2%
0.01%
+1200.0%
Q3 2021$7,0000.0%810.0%0.00%0.0%
Q2 2021$7,000
-58.8%
81
-59.7%
0.00%
-50.0%
Q1 2021$17,000
+750.0%
201
+905.0%
0.00%
Q2 2020$2,0000.0%20
-25.9%
0.00%
Q2 2016$2,000
-88.9%
27
-89.2%
0.00%
-100.0%
Q1 2016$18,000
-18.2%
2510.0%0.01%
-16.7%
Q4 2015$22,000
+4.8%
251
+10.1%
0.01%
+20.0%
Q3 2015$21,000
-4.5%
2280.0%0.01%
-16.7%
Q2 2015$22,0000.0%2280.0%0.01%
+20.0%
Q1 2015$22,000
+4.8%
2280.0%0.01%
-16.7%
Q4 2014$21,000
+10.5%
2280.0%0.01%0.0%
Q3 2014$19,0000.0%2280.0%0.01%0.0%
Q2 2014$19,0000.0%2280.0%0.01%0.0%
Q1 2014$19,000
-70.3%
228
-69.5%
0.01%
-82.9%
Q3 2013$64,000
+4.9%
748
+4.6%
0.04%
-5.4%
Q2 2013$61,0000.0%7150.0%0.04%
+5.7%
Q1 2013$61,0000.0%7150.0%0.04%
-5.4%
Q4 2012$61,0000.0%7150.0%0.04%
-7.5%
Q3 2012$61,0000.0%7150.0%0.04%
+8.1%
Q2 2012$61,0000.0%7150.0%0.04%0.0%
Q1 2012$61,0000.0%7150.0%0.04%
-9.8%
Q4 2011$61,0007150.04%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders